Exosomal miR-122 derived from M2 macrophages induces osteogenic differentiation of bone marrow mesenchymal stem cells in the treatment of alcoholic osteonecrosis of the femoral head

被引:0
|
作者
Le, Guoping [1 ]
Wen, Riyou [1 ]
Fang, Huaixi [1 ]
Huang, Zhifa [1 ]
Wang, Yong [1 ]
Luo, Hanwen [1 ]
机构
[1] Liuzhou Workers Hosp, Dept Joint Osteopathy, Liuzhou 545000, Guangxi, Peoples R China
来源
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH | 2025年 / 20卷 / 01期
关键词
Alcoholic osteonecrosis of the femoral head; M2; macrophages; Exosomes; miR-122; ENDOCHONDRAL OSSIFICATION; NECROSIS;
D O I
10.1186/s13018-025-05515-7
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Alcoholic osteonecrosis of the femoral head (AIONFH) is caused by long-term heavy drinking, which leads to abnormal alcohol and lipid metabolism, resulting in femoral head tissue damage, and then pathological necrosis of femoral head tissue. If not treated in time in clinical practice, it will seriously affect the quality of life of patients and even require hip replacement to treat alcoholic femoral head necrosis. This study will confirm whether M2 macrophage exosome (M2-Exo) miR-122 mediates alcohol-induced BMSCs osteogenic differentiation, ultimately leading to the inhibition of femoral head necrosis. M2 macrophages were identified by flow cytometry, and the isolated exosomes were characterized by transmission electron microscopy (TEM) and Nanoparticle Tracking Analysis (NTA). Next, miR-122 was overexpressed by transfecting miR-122 mimic, and the expression of miR-122 in M2 macrophages and their exosomes was evaluated. Subsequently, the effect of exosomal miR-122 on the osteogenic differentiation ability of BMSCs was detected, including cell proliferation, expression of osteogenic-related genes (RUNX2, BMP2, OPN, ALP), and calcium nodule formation. Finally, the therapeutic effect of M2-Exo was analyzed in a rat model of AIONFH, and bone repair and pathological damage were evaluated by Micro-CT, RT-qPCR, HE, Masson staining, and immunohistochemistry (COL I). The results showed that M2 macrophages were successfully polarized, with an average M2-Exo particle size of 156.4 nm and a concentration of 3.2E + 12 particles/mL. The expression of miR-122 in M2 macrophages is significantly higher than that in M0 macrophages, and miR-122 mimic can increase the content of miR-122 in M2-Exo. miR-122 in M2-Exo can promote osteogenic differentiation of rat bone marrow BMSCs, enhance cell viability, and increase the expression of osteogenesis-related genes. After being applied to the AIONFH rat model, the injection of M2-exo and miR-122 mimics significantly improved the repair effect of articular cartilage, alleviated pathological changes, and promoted the regeneration of bone tissue. M2-macrophage-derived exosomal miR-122 induces osteogenic differentiation of bone mesenchymal stem cells in treating AIONFH.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head
    Wang, Cheng
    Wang, Yu
    Meng, Hao-Ye
    Yuan, Xue-Ling
    Xu, Xiao-Long
    Wang, Ai-Yuan
    Guo, Quan-Yi
    Peng, Jiang
    Lu, Shi-Bi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3127 - 3135
  • [2] M2 macrophagy-derived exosomal miRNA-26a-5p induces osteogenic differentiation of bone mesenchymal stem cells
    Bin-bin, Zhang
    Da-wa, Zha Xi
    Chao, Li
    Lan-tao, Zhang
    Tao, Wu
    Chuan, Lu
    Chao-zheng, Liu
    De-chun, Li
    Chang, Feng
    Shu-qing, Wei
    Zu-nan, Dong
    Xian-wei, Pei
    Zhang, Zhi-xia
    Ke-wen, Li
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2022, 17 (01)
  • [3] M2 macrophagy-derived exosomal miRNA-26a-5p induces osteogenic differentiation of bone mesenchymal stem cells
    Zhang Bin-bin
    Zha Xi Da-wa
    Li Chao
    Zhang Lan-tao
    Wu Tao
    Lu Chuan
    Liu Chao-zheng
    Li De-chun
    Feng Chang
    Wei Shu-qing
    Dong Zu-nan
    Pei Xian-wei
    Zhi-xia Zhang
    Li Ke-wen
    Journal of Orthopaedic Surgery and Research, 17
  • [4] Cajan leaf combined with bone marrow-derived mesenchymal stem cells for the treatment of osteonecrosis of the femoral head
    Shi, Da
    Sun, Yindi
    Yin, Jichao
    Fan, Xiaochen
    Duan, Honghao
    Liu, Na
    He, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (06) : 1471 - 1475
  • [5] M2 macrophage-derived exosomal miR-486-5p influences the differentiation potential of bone marrow mesenchymal stem cells and osteoporosis
    Liu, Jincheng
    Sun, Zhenqian
    You, Yunhao
    Zhang, Lu
    Hou, Dehui
    Gu, Guanghui
    Chen, Yunzhen
    Jiao, Guangjun
    AGING-US, 2023, 15 (18): : 9499 - 9520
  • [6] Amelogenin Enhances the Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Bone Marrow
    Tanimoto, K.
    Huang, Y. C.
    Tanne, Y.
    Kunimatsu, R.
    Michida, M.
    Yoshioka, M.
    Ozaki, N.
    Sasamoto, T.
    Yoshimi, Y.
    Kato, Y.
    Tanne, K.
    CELLS TISSUES ORGANS, 2012, 196 (05) : 411 - 419
  • [7] Human Bone Marrow Mesenchymal Stem Cells Promote the M2 Phenotype in Macrophages Derived from STEMI Patients
    Cortes-Morales, Victor Adrian
    Vazquez-Gonzalez, Wendy Guadalupe
    Montesinos, Juan Jose
    Moreno-Ruiz, Luis
    Salgado-Pastor, Selene
    Salinas-Arreola, Pamela Michelle
    Diaz-Duarte, Karla
    Chavez-Rueda, Adriana Karina
    Chavez-Sanchez, Luis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [8] Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head
    Fang, Shanhong
    Li, Yongfeng
    Chen, Peng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 45 - 55
  • [9] Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells
    Zhao, Dewei
    Cui, Daping
    Wang, Benjie
    Tian, Fengde
    Guo, Lin
    Yang, Lei
    Liu, Baoyi
    Yu, Xiaobing
    BONE, 2012, 50 (01) : 325 - 330
  • [10] Osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with myeloproliferative disorders
    Lee, HS
    Tang, JL
    Chiou, LL
    Tsai, KS
    Jiang, CC
    Yang, PC
    Yang, PM
    Huang, GT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (02) : 124 - 128